Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer von Al Amri, Waked S., Allinson, Lisa M., Baxter, Diana E., Bell, Sandra M., Hanby, Andrew M., Jones, Stacey J., Shaaban, Abeer M., Stead, Lucy F., Verghese, Eldo T., Hughes, Thomas A.

Volltext

Loss of ALK hotspot mutations in relapsed neuroblastoma von Allinson, Lisa M., Potts, Aaron, Goodman, Angharad, Bown, Nick, Bashton, Matthew, Thompson, Dean, Basta, Nermine O., Gabriel, Alem S., McCorkindale, Michael, Ng, Antony, McNally, Richard J. Q., Tweddle, Deborah A.

Volltext

MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer von Baxter, Diana E., Allinson, Lisa M., Al Amri, Waleed S., Poulter, James A., Pramanik, Arindam, Thorne, James L., Verghese, Eldo T., Hughes, Thomas A.

Volltext

Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma von Barford, Ruby G, Whittle, Emily, Weir, Laura, Fong, Fang Chyi, Goodman, Angharad, Hartley, Hannah E, Allinson, Lisa M, Tweddle, Deborah A

Volltext

PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia von Herriott, Ashleigh, Tudhope, Susan J, Junge, Gesa, Rodrigues, Natalie, Patterson, Miranda J, Woodhouse, Laura, Lunec, John, Hunter, Jill E, Mulligan, Evan A, Cole, Michael, Allinson, Lisa M, Wallis, Jonathan P, Marshall, Scott, Wang, Evelyn, Curtin, Nicola J, Willmore, Elaine

Volltext